Colin Dayan

20.6k total citations · 5 hit papers
278 papers, 12.1k citations indexed

About

Colin Dayan is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Colin Dayan has authored 278 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 155 papers in Endocrinology, Diabetes and Metabolism, 93 papers in Genetics and 60 papers in Surgery. Recurrent topics in Colin Dayan's work include Diabetes and associated disorders (75 papers), Thyroid Disorders and Treatments (70 papers) and Diabetes Management and Research (54 papers). Colin Dayan is often cited by papers focused on Diabetes and associated disorders (75 papers), Thyroid Disorders and Treatments (70 papers) and Diabetes Management and Research (54 papers). Colin Dayan collaborates with scholars based in United Kingdom, United States and Australia. Colin Dayan's co-authors include Peter Taylor, Gilbert H. Daniels, Mark Peakman, Onyebuchi Okosieme, Timothy Tree, Ponnusamy Saravanan, Vijay Panicker, John H. Lazarus, Bart O. Roep and Amanda J. Bishop and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Colin Dayan

259 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global epidemiology of hyperthyroidism and hypothyroidism

2018 884 citations Peter Taylor, Colin Dayan et al. profile →
Defective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes

2005 676 citations Colin Dayan, Amanda J. Bishop et al. Diabetes profile →
Chronic Autoimmune Thyroiditis

1996 635 citations Colin Dayan et al. profile →
Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective

2022 117 citations Emily K. Sims, Rachel Besser et al. Diabetes profile →
Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes

2023 111 citations Colin Dayan, Kevan C. Herold et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colin Dayan United Kingdom	58	6.6k	3.5k	2.5k	2.2k	1.3k	278	12.1k
Kenneth D. Burman United States	55	9.3k 1.4×	1.4k 0.4×	676 0.3×	2.0k 0.9×	1.2k 1.0×	310	13.3k
Fred C.G.J. Sweep Netherlands	73	3.4k 0.5×	1.8k 0.5×	1.7k 0.7×	2.1k 0.9×	957 0.7×	491	18.5k
Martin O. Savage United Kingdom	57	8.9k 1.4×	3.4k 1.0×	620 0.2×	3.4k 1.5×	413 0.3×	268	12.8k
Carl D. Langefeld United States	66	1.9k 0.3×	4.0k 1.1×	2.9k 1.2×	1.5k 0.7×	1.3k 1.0×	423	17.6k
Glenn D. Braunstein United States	54	5.1k 0.8×	1.4k 0.4×	673 0.3×	1.8k 0.8×	828 0.6×	230	11.5k
Yasuhiro Ito Japan	67	11.8k 1.8×	1.8k 0.5×	848 0.3×	8.2k 3.7×	1.0k 0.8×	505	19.0k
Myron A. Waclawiw United States	56	1.9k 0.3×	1.3k 0.4×	1.3k 0.5×	2.0k 0.9×	639 0.5×	139	14.9k
Martin den Heijer Netherlands	64	1.9k 0.3×	1.5k 0.4×	688 0.3×	2.5k 1.1×	705 0.6×	371	16.2k
Michael A. Levine United States	69	2.3k 0.4×	4.9k 1.4×	501 0.2×	2.3k 1.0×	1.8k 1.4×	371	16.1k
Thomas Quertermous United States	71	1.6k 0.2×	2.2k 0.6×	2.6k 1.0×	3.3k 1.5×	551 0.4×	303	17.2k

Countries citing papers authored by Colin Dayan

Since Specialization

Citations

This map shows the geographic impact of Colin Dayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Dayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Dayan more than expected).

Fields of papers citing papers by Colin Dayan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Dayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Dayan. The network helps show where Colin Dayan may publish in the future.

Co-authorship network of co-authors of Colin Dayan

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Dayan. A scholar is included among the top collaborators of Colin Dayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Dayan. Colin Dayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Asderakis, Argiris, G. Mortimer, L. Szabó, et al.. (2025). Beta Cell Specific Cell Free DNA and Trypsinogen for the Diagnosis of Rejection in Pancreas Transplantation The EMPAR Study. American Journal of Transplantation. 25(8). S201–S201.

Taylor, Peter, Lakdasa Premawardhana, Mike Stedman, et al.. (2025). Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis. The Journal of Clinical Endocrinology & Metabolism. 110(11). 3278–3288. 1 indexed citations

Latres, Esther, Carla J. Greenbaum, Colin Dayan, et al.. (2024). Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes. Diabetes. 73(6). 823–833. 15 indexed citations

Rampelbergh, Jean Van, Peter Achenbach, Richard David Leslie, et al.. (2023). First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes. BMC Medicine. 21(1). 190–190. 13 indexed citations

Premawardhana, Lakdasa, et al.. (2023). Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design. Frontiers in Endocrinology. 14. 1282608–1282608. 4 indexed citations

Mulder, Tessa A., Purdey J. Campbell, Peter Taylor, et al.. (2023). Genetic determinants of thyroid function in children. European Journal of Endocrinology. 189(2). 164–174.

Sims, Emily K., Rachel Besser, Colin Dayan, et al.. (2022). Screening for Type 1 Diabetes in the General Population: A Status Report and Perspective. Diabetes. 71(4). 610–623. 117 indexed citations breakdown →

Taylor, Peter, et al.. (2022). Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data. Diabetic Medicine. 39(9). e14908–e14908. 1 indexed citations

Draman, Mohd Shazli, Peter Taylor, Ilaria Muller, et al.. (2021). Expression of Endogenous Putative TSH Binding Protein in Orbit. Current Issues in Molecular Biology. 43(3). 1794–1804. 5 indexed citations

10.

Okosieme, Onyebuchi, Jackie Gilbert, Kristien Boelaert, et al.. (2021). Thyrotoxicosis and hyperthyroidism: causes, diagnosis and management. Pharmaceutical journal/The pharmaceutical journal.

11.

Lewis, S.A.E., et al.. (2021). Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta‐analysis. Clinical Endocrinology. 96(6). 857–868. 12 indexed citations

12.

Stedman, Mike, Peter Taylor, Lakdasa Premawardhana, et al.. (2021). Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011–2020. Clinical Endocrinology. 94(6). 980–989. 12 indexed citations

13.

Kneale, Dylan, et al.. (2020). Type 1 diabetes mellitus and educational attainment in childhood: a systematic review. BMJ Open. 10(1). e033215–e033215. 18 indexed citations

14.

Kneale, Dylan, et al.. (2018). Association between type 1 diabetes mellitus and educational attainment in childhood: a systematic review protocol. BMJ Open. 8(8). e021893–e021893. 5 indexed citations

15.

Dayan, Colin, et al.. (2010). İnmelerde tekrarlayıcılığı etkileyen risk faktörleri. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 38–43. 1 indexed citations

16.

Dayan, Colin, et al.. (2010). Risk factors that affect recurrence in strokes. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 38–43. 1 indexed citations

17.

Panicker, Vijay, Ponnusamy Saravanan, Bijay Vaidya, et al.. (2009). Common Variation in the DIO2 Gene Predicts Baseline Psychological Well-Being and Response to Combination Thyroxine Plus Triiodothyronine Therapy in Hypothyroid Patients. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1623–1629. 238 indexed citations

18.

Hermanides, Jeroen, Kirsten Nørgaard, Daniela Bruttomesso, et al.. (2009). Sensor augmented pump therapy substantially lowers HbA(1c); a randomized controlled trial. Lund University Publications (Lund University). 6 indexed citations

19.

Arif, Sefina, Timothy Tree, Jennifer Tremble, et al.. (2004). Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. Journal of Clinical Investigation. 113(3). 451–463. 401 indexed citations

20.

Maile, Robert, et al.. (1998). Effective formation by thyroid epithelial cells of MHC Class II-peptide complexes derived from endogenous antigen. Immunology. 95. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact